| Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients R Cervera, MA Khamashta, J Font, GD Sebastiani, A Gil, P Lavilla, ... Medicine 82 (5), 299-308, 2003 | 1799 | 2003 |
| Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis P Alba, L Bento, MJ Cuadrado, Y Karim, MF Tungekar, I Abbs, ... Annals of the rheumatic diseases 62 (6), 556-560, 2003 | 305 | 2003 |
| Mycophenolate mofetil for systemic lupus erythematosus refractory to other immunosuppressive agents MY Karim, P Alba, MJ Cuadrado, IC Abbs, DP D'Cruz, MA Khamashta, ... Rheumatology 41 (8), 876-882, 2002 | 227 | 2002 |
| Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature M Ramos-Casals, MJ Cuadrado, P Alba, G Sanna, P Brito-Zerón, ... Medicine 87 (6), 311-318, 2008 | 224 | 2008 |
| The 2023 ACR/EULAR antiphospholipid syndrome classification criteria M Barbhaiya, S Zuily, R Naden, A Hendry, F Manneville, MC Amigo, ... Arthritis & Rheumatology 75 (10), 1687-1702, 2023 | 188 | 2023 |
| Mycophenolate mofetil as a treatment for autoimmune haemolytic anaemia in patients with systemic lupus erythematosus and antiphospholipid syndrome P Alba, MY Karim, BJ Hunt Lupus 12 (8), 633-635, 2003 | 111 | 2003 |
| Impact of genetic ancestry and sociodemographic status on the clinical expression of systemic lupus erythematosus in American Indian–European populations E Sánchez, A Rasmussen, L Riba, E Acevedo‐Vasquez, JA Kelly, ... Arthritis & Rheumatism 64 (11), 3687-3694, 2012 | 101 | 2012 |
| Metabolic syndrome in Argentinean patients with systemic lupus erythematosus V Bellomio, A Spindler, E Lucero, A Berman, R Sueldo, H Berman, ... Lupus 18 (11), 1019-1025, 2009 | 98 | 2009 |
| Development of a new international antiphospholipid syndrome classification criteria phase I/II report: generation and reduction of candidate criteria M Barbhaiya, S Zuily, Y Ahmadzadeh, MC Amigo, T Avcin, ... Arthritis care & research 73 (10), 1490-1501, 2021 | 77 | 2021 |
| Allelic heterogeneity in NCF2 associated with systemic lupus erythematosus (SLE) susceptibility across four ethnic populations X Kim-Howard, C Sun, JE Molineros, AK Maiti, H Chandru, A Adler, ... Human molecular genetics 23 (6), 1656-1668, 2014 | 74 | 2014 |
| Hypertension as the presenting feature of the antiphospholipid syndrome MY Karim, P Alba, MF Tungekar, IC Abbs, MA Khamashta, GRV Hughes, ... Lupus 11 (4), 253-256, 2002 | 32 | 2002 |
| Organ damage and quality of life in antiphospholipid syndrome P Alba, JA Gómez-Puerta, MV Goycochea-Robles, MC Amigo Current rheumatology reports 18, 1-7, 2016 | 17 | 2016 |
| Lack of association of antibodies to ribosomal P proteins with lupus membranous glomerulonephritis: comment on the article by Do Nascimento et al. ML Bertolaccini, V Murru, P Alba, MA Khamashta Arthritis and rheumatism 54 (12), 4025-6; author reply 4026, 2006 | 14 | 2006 |
| Thermography in systemic sclerosis patients and other rheumatic diseases: diagnosis, disease activity assessment, and therapeutic monitoring S Sciascia, I Cecchi, C Massara, D Rossi, M Radin, PL Ladehesa, ... Autoimmunity Reviews, 0-0, 2020 | 13 | 2020 |
| Medium vessel vasculitis in systemic lupus erythematosus A Maldonado, JN Blanzari, P Asbert, JA Albiero, C Gobbi, E Albiero, ... Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) 73 (1), 50-52, 2016 | 13 | 2016 |
| Clinical guidelines for the management of acute viral infections in patients with systemic lupus erythematosus. M Ramos-Casals, MJ Cuadrado, P Alba, G Sanna, P Brito-Zerón, ... Minerva medica 100 (6), 437-446, 2009 | 13 | 2009 |
| Work disability in Argentinian patients with systemic lupus erythematosus is prevalent and it is due to ethnic, socioeconomic and disease‐related factors CN Pisoni, SA Muñoz, MN Tamborenea, M García, A Curti, A Cappuccio, ... International Journal of Rheumatic Diseases 21 (11), 2019-2027, 2018 | 12 | 2018 |
| Multicenter study to assess presenteeism in systemic lupus erythematosus and its relationship with clinical and sociodemographic features MA Cosatti, S Muñoz, P Alba, CA Helling, S Roverano, J Sarano, ... Lupus 27 (1), 33-39, 2018 | 11 | 2018 |
| The use of laboratory methods in differential diagnosis and treatment of SLE and antiphospholipid syndrome P Alba, ML Bertolaccini, MA Khamashta Expert Review of Clinical Immunology 3 (4), 613-622, 2007 | 7 | 2007 |
| Subclinical markers of atherosclerosis and cardiovascular risk factors in early arthritis. CA Gobbi, P Asbert, PB Alba, J Resk, G Dotto, M Demarchi, E Cuvertino, ... Revista de la Facultad de Ciencias Medicas (Cordoba, Argentina) 76 (3), 174-179, 2019 | 6 | 2019 |
